Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

Related Keywords

United States ,San Antonio ,Texas ,American ,Mike Catelani ,Anixa Biosciences ,Stephen Kilmer ,Amit Kumar ,G Thomas Budd ,Vincent Tuohy ,Cleveland Clinic Lerner Research Institute ,Us Department Of Defense ,Innovative Breast Cancer Research ,Youtube ,Cleveland Clinic Cancer Institute ,Linkedin ,Department Of Inflammation ,Moffitt Cancer Center ,Anixa Biosciences Inc ,Facebook ,Cleveland Clinic ,Antonio Breast Cancer Symposium ,Dose Level ,Call Details ,Iris November Distinguished Chair ,Lerner Research ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Clinical Trials Amp Medical Discoveries ,